Targeting castration-resistant prostate cancer with monoclonal antibodies and constructs
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting castration-resistant prostate cancer with monoclonal antibodies and constructs
Authors
Keywords
-
Journal
Immunotherapy
Volume 5, Issue 12, Pages 1347-1355
Publisher
Future Medicine Ltd
Online
2013-11-27
DOI
10.2217/imt.13.140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC).
- (2017) Daniel Costin Danila et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
- (2013) S. F. Slovin et al. ANNALS OF ONCOLOGY
- Characterization of the drug-to-antibody ratio distribution for antibody–drug conjugates in plasma/serum
- (2013) Keyang Xu et al. Bioanalysis
- A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer
- (2012) M. J. Morris et al. ANNALS OF ONCOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer
- (2012) Susan F. Slovin et al. VACCINE
- Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial
- (2011) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Circulating Tumor Cells as Biomarkers in Prostate Cancer
- (2011) D. C. Danila et al. CLINICAL CANCER RESEARCH
- Antibody Conjugate Therapeutics: Challenges and Potential
- (2011) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule?
- (2010) N. Saeki et al. CLINICAL CANCER RESEARCH
- Diversity in antibody-based approaches to non-Hodgkin lymphoma
- (2010) David Maloney et al. LEUKEMIA & LYMPHOMA
- Maytansine and Cellular Metabolites of Antibody-Maytansinoid Conjugates Strongly Suppress Microtubule Dynamics by Binding to Microtubules
- (2010) M. Lopus et al. MOLECULAR CANCER THERAPEUTICS
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Do We Need a Different Set of Response Assessment Criteria for Tumor Immunotherapy?
- (2009) A. Ribas et al. CLINICAL CANCER RESEARCH
- Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer
- (2008) Matthew D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now